PubRank

Hirohito Tsubouchi

Author PubWeight™ 131.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012 7.39
2 Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer 2011 2.81
3 Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan. J Hepatol 2011 2.18
4 Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 2004 2.03
5 Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology 2010 1.83
6 Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 2012 1.72
7 Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology 2009 1.66
8 Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease. Intern Med 2003 1.64
9 Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey. Liver Transpl 2012 1.64
10 Relationship between weather and onset of acute myocardial infarction: can days of frequent onset be predicted? J Cardiol 2009 1.52
11 Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology 2007 1.51
12 Early prediction of short-term development of hepatic encephalopathy in patients with acute liver disease unrelated to paracetamol. A prospective study in Japan. J Hepatol 2009 1.43
13 Activation of hepatocyte growth factor in monkey stomach following gastric mucosal injury. J Gastroenterol 2004 1.38
14 Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003 1.35
15 Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet 2012 1.32
16 Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 2004 1.31
17 Glutamine increases autophagy under Basal and stressed conditions in intestinal epithelial cells. Gastroenterology 2008 1.23
18 Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies. J Gastroenterol 2014 1.19
19 Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 2004 1.19
20 Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 2003 1.14
21 Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009 1.12
22 Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood 2008 1.09
23 Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J Hepatol 2003 1.08
24 Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol 2011 1.05
25 BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007 1.05
26 Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011 1.05
27 Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy. Hepatol Res 2012 1.05
28 Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA. J Biol Chem 2009 1.04
29 Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol 2005 1.03
30 Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety. J Transl Med 2011 1.02
31 The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis 2005 1.02
32 Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 2013 1.01
33 Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study. Hepatol Res 2014 1.00
34 Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels. Hepat Mon 2012 0.99
35 Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 2006 0.98
36 Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatol Res 2015 0.98
37 Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 2013 0.96
38 Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats. J Gastroenterol Hepatol 2005 0.95
39 Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years. J Hepatobiliary Pancreat Sci 2014 0.95
40 Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan. Int J Cancer 2006 0.94
41 Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res 2011 0.94
42 Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men. Hepatol Res 2008 0.93
43 Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohn's disease. Inflamm Bowel Dis 2008 0.93
44 The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol 2009 0.93
45 Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan. Hepatol Res 2005 0.93
46 Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res 2011 0.92
47 Liver regeneration after partial hepatectomy in rat is more impaired in a steatotic liver induced by dietary fructose compared to dietary fat. Biochem Biophys Res Commun 2011 0.90
48 Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults. Cancer Epidemiol Biomarkers Prev 2004 0.90
49 Changing etiologies and outcomes of acute liver failure: A perspective from Japan. J Gastroenterol Hepatol 2011 0.90
50 The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet. Hepatol Res 2005 0.89
51 Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy. J Gastroenterol 2008 0.89
52 Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. J Infect Dis 2002 0.88
53 Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study. Exp Ther Med 2011 0.88
54 Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia. J Gastroenterol 2013 0.88
55 Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C. Mol Med Rep 2012 0.87
56 Inhibition of tumor-stromal interaction through HGF/Met signaling by valproic acid. Biochem Biophys Res Commun 2007 0.87
57 Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C. BMC Gastroenterol 2014 0.87
58 Algorithm to determine the outcome of patients with acute liver failure: a data-mining analysis using decision trees. J Gastroenterol 2012 0.86
59 Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia. Leuk Lymphoma 2005 0.86
60 Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs. Acta Otolaryngol 2009 0.86
61 Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology 2013 0.85
62 Novel classification of acute liver failure through clustering using a self-organizing map: usefulness for prediction of the outcome. J Gastroenterol 2011 0.85
63 Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oncol Rep 2011 0.85
64 Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Sci 2007 0.85
65 HCV core antigen as an alternative to NAT to detect HCV viremia. Transfusion 2004 0.85
66 Branched-chain amino acids supplements in the late evening decrease the frequency of muscle cramps with advanced hepatic cirrhosis. Hepatol Res 2003 0.84
67 Molecular mechanisms of hereditary persistence of alpha-fetoprotein (AFP) in two Japanese families A hepatocyte nuclear factor-1 site mutation leads to induction of the AFP gene expression in adult livers. Hepatol Res 2005 0.84
68 Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. Proteome Sci 2010 0.84
69 Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis. Inflamm Bowel Dis 2009 0.84
70 Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis. Hepatol Res 2004 0.84
71 Clinical profiles of patients with primary sclerosing cholangitis in the elderly. J Hepatobiliary Pancreat Sci 2014 0.84
72 Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria. Biochem Biophys Res Commun 2004 0.84
73 Effect of endoscopic submucosal dissection for superficial esophageal neoplasms and risk factors for postoperative stricture. Medicine (Baltimore) 2015 0.84
74 Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol 2010 0.83
75 Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in Doxorubicin-induced cardiomyopathy. Stem Cells 2005 0.83
76 Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet. Liver Int 2013 0.83
77 Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats. Biochem Biophys Res Commun 2007 0.83
78 Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study. Hepatol Res 2013 0.83
79 Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma. World J Gastroenterol 2011 0.83
80 Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial. Hepatol Int 2009 0.83
81 Translational research to identify clinical applications of hepatocyte growth factor. Hepatol Res 2009 0.83
82 Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2011 0.82
83 Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J Mol Med 2006 0.82
84 Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response. J Gastroenterol 2004 0.82
85 Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Inflamm Bowel Dis 2005 0.82
86 Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. Hepatol Res 2007 0.82
87 Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: a nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev 2006 0.82
88 Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol 2004 0.82
89 Hepatocyte growth factor protects auditory hair cells from aminoglycosides. Laryngoscope 2009 0.81
90 The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D. BMC Pulm Med 2012 0.81
91 Human neutrophil peptide-1 aggravates dextran sulfate sodium-induced colitis. Inflamm Bowel Dis 2011 0.81
92 Translational research on HGF: A phase I/II study of recombinant human HGF for the treatment of fulminant hepatic failure. Hepatol Res 2008 0.80
93 Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis. Life Sci 2011 0.80
94 Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat. Eur J Med Res 2013 0.80
95 Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C. J Gastroenterol 2009 0.80
96 Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion: proteomic approach using fluorescent two-dimensional differential gel electrophoresis. Hum Cell 2013 0.80
97 Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan. J Gastroenterol 2007 0.80
98 Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: Application to indication criteria for liver transplantation. Hepatol Res 2011 0.80
99 Rapid phenotypic assay for human immunodeficiency virus type 1 protease using in vitro translation. J Virol Methods 2002 0.79
100 Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I. J Med Virol 2006 0.79
101 Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma. Exp Ther Med 2012 0.79
102 A CRE and the region occupied by a protein induced by growth factors contribute to up-regulation of cyclin D1 expression in hepatocytes. Biochem Biophys Res Commun 2003 0.79
103 Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B. Hepatol Int 2008 0.79
104 In vitro translation to study HIV protease activity. Methods Mol Biol 2007 0.79
105 Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetol Metab Syndr 2012 0.79
106 Correlation of serum levels of complement C4a desArg with pathologically estimated severity of glomerular lesions and mesangial hypercellularity scores in patients with IgA nephropathy. Int J Mol Med 2013 0.78
107 Hepatocyte growth factor ameliorates mucosal injuries leading to inhibition of colon cancer development in mice. Oncol Rep 2011 0.78
108 Hepatocyte growth factor improves the survival of rats with pulmonary arterial hypertension via the amelioration of pulmonary hemodynamics. Int J Mol Med 2011 0.78
109 Endoscopic ultrasonography-guided transmural drainage of an infected hepatic cyst due to Edwardsiella tarda: a case report. Clin J Gastroenterol 2014 0.78
110 Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. J Gastroenterol 2015 0.78
111 Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method. Hepatol Res 2010 0.78
112 Possible involvement of neutrophils in a serum level increase of hepatocyte growth factor in non-Hodgkin's lymphoma. Oncol Rep 2005 0.78
113 Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population. J Gastroenterol 2013 0.78
114 [Effectiveness of humanized anti-interleukin-6 receptor antibody (tocilizumab) for Castleman's disease mainly with pulmonary involvement]. Nihon Naika Gakkai Zasshi 2007 0.78
115 Modulation of hepatocyte growth factor induction in human skin fibroblasts by retinoic acid. Biochim Biophys Acta 2005 0.78
116 Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res 2004 0.77
117 Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. Int J Mol Med 2013 0.77
118 Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Gastroenterol 2014 0.77
119 Mitogen-activated protein kinases-dependent induction of hepatocyte growth factor production in human dermal fibroblasts by the antibiotic polymyxin B. Cytokine 2012 0.77
120 Induction of hepatocyte growth factor production in human dermal fibroblasts and their proliferation by the extract of bitter melon pulp. Cytokine 2009 0.77
121 Activation of complement system in adult T-cell leukemia (ATL) occurs mainly through lectin pathway: a serum proteomic approach using mass spectrometry. Cancer Lett 2008 0.77
122 Proanthocyanidin derived from the leaves of Vaccinium virgatum suppresses platelet-derived growth factor-induced proliferation of the human hepatic stellate cell line LI90. Hepatol Res 2010 0.77
123 Apolipoprotein E regulates primary cultured human mesangial cell proliferation. Nephron Exp Nephrol 2005 0.77
124 Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA. J Gastroenterol 2014 0.77
125 [Mycoplasma pneumonia of identical twin sisters with different clinical courses depending on the treatment]. Kansenshogaku Zasshi 2002 0.77
126 Growth factor-eluting cochlear implant electrode: impact on residual auditory function, insertional trauma, and fibrosis. J Transl Med 2014 0.77
127 Hepatocyte growth factor stimulates the migration of gastric epithelial cells by altering the subcellular localization of the tight junction protein ZO-1. J Gastroenterol 2012 0.77
128 Management of hepatitis B virus-related acute liver failure. Clin J Gastroenterol 2014 0.76
129 Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis. Hepatol Res 2014 0.76
130 Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study. Ther Apher Dial 2014 0.76
131 Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation. Circ J 2009 0.76
132 Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy. Biochem Biophys Res Commun 2010 0.76
133 Hepatocyte growth factor sustains T regulatory cells and prolongs the survival of kidney allografts in major histocompatibility complex-inbred CLAWN-miniature swine. Transplantation 2012 0.76
134 Polyamines mediate glutamine-dependent induction of the intestinal epithelial heat shock response. Am J Physiol Gastrointest Liver Physiol 2011 0.76
135 Effects of hepatocyte growth factor in myocarditis rats induced by immunization with porcine cardiac myosin. Interact Cardiovasc Thorac Surg 2013 0.76
136 Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort. J Gastroenterol 2013 0.76
137 Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma. Oncol Lett 2010 0.75
138 Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid. Biol Pharm Bull 2005 0.75
139 Sustained activation of epidermal growth factor receptor in cholangiocarcinoma: a potent therapeutic target? J Hepatol 2004 0.75
140 [Congenital generalized lipodystrophy with diabetic triopathy]. Nihon Naika Gakkai Zasshi 2007 0.75
141 [Prevention and management of hepatitis B virus reactivation during anticancer or immunosuppressive therapy]. Nihon Rinsho 2011 0.75
142 [Hepatocyte growth factor--history of discovery, physiological roles in dentistry and clinical application]. Seikagaku 2004 0.75
143 Development of a rapid semi-quantitative immunochromatographic assay for serum hepatocyte growth factor and its usefulness in acute liver failure. Hepatol Res 2005 0.75
144 Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis: A multicenter study in Japan. Hepatol Res 2012 0.75
145 [Chronic liver disease and arteriosclerosis]. Nihon Rinsho 2011 0.75
146 Gastroesophageal reflux symptoms in adults with skeletal Class III malocclusion examined by questionnaires. Am J Orthod Dentofacial Orthop 2009 0.75
147 High serum thioredoxin levels are reduced after tonsillectomy in patients with IgA nephropathy. Intern Med 2012 0.75
148 Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by interleukin-1 and its prevention by interferon-gamma. Biochem Biophys Res Commun 2004 0.75
149 Irrelevant B-type natriuretic peptide levels in patients with mechanical prostheses in the mitral position presenting with congestive heart failure. Circ J 2010 0.75
150 Editorial. Hepatol Res 2007 0.75
151 [Diagnostic biomarkers in inflammatory bowel disease]. Nihon Rinsho 2012 0.75
152 Timing of interferon therapy and sources of infection in patients with acute hepatitis C. Hepatol Res 2005 0.75
153 Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti-HCV antibody in an HCV hyperendemic area in Japan. J Med Virol 2014 0.75
154 [Proposal of novel staging and grading system of primary biliary cirrhosis]. Nihon Shokakibyo Gakkai Zasshi 2011 0.75
155 [Case of multiple nodular lesions of bilateral kidneys with IgG4-related systemic disease]. Nihon Jinzo Gakkai Shi 2008 0.75
156 Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet. Oncol Rep 2006 0.75
157 Acute hepatic failure due to hepatic involvement by chronic lymphocytic leukemic cells in a patient with chronic hepatitis B. J Gastroenterol 2004 0.75
158 [ATL (lymphoma type) presented with a mass formation in the heart]. Rinsho Ketsueki 2002 0.75
159 [Disease-specific biomarkers of inflammatory bowel disease]. Nihon Rinsho 2012 0.75
160 [Reactivation of Hepatitis B Virus and Guidelines for Its Prevention]. Rinsho Byori 2015 0.75
161 [A case of chronic hepatitis C with interferon-induced retinopathy worsen after termination of treatment]. Nihon Shokakibyo Gakkai Zasshi 2003 0.75
162 Prognosis of autoimmune hepatitis showing acute presentation. Hepatol Res 2012 0.75
163 Navigator-echo-based MR provides high-resolution images and precise volumetry of swine livers without breath holding or injection of contrast media. Liver Transpl 2006 0.75
164 [National surveys of primary biliary cirrhosis (PBC) in Japan]. Nihon Shokakibyo Gakkai Zasshi 2013 0.75
165 Detection of human T-lymphotropic virus type I (HTLV-I) infection during coculture of HTLV-I infected and uninfected cells using inverse long PCR. Intervirology 2002 0.75
166 Enhanced cell-substratum adhesion of E-cadherin-expressing cells is mediated by activation of the small GTPase protein, Rac1. Int J Mol Med 2006 0.75
167 Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan. J Gastroenterol 2008 0.75
168 [Development of an innovative therapy for inflammatory bowel disease using recombinant human hepatocyte growth factor to facilitate intestinal mucosal repair]. Nihon Shokakibyo Gakkai Zasshi 2005 0.75
169 [Current status and prevention of fulminant hepatitis due to hepatitis B reactivation]. Nihon Shokakibyo Gakkai Zasshi 2010 0.75
170 [HGF therapy to support liver regeneration]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75
171 Adenosine stress thallium-201 myocardial scintigraphy. J Cardiol 2007 0.75
172 Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan. Hepatol Res 2010 0.75
173 Effect of dietary blueberry (Vaccinium ashei Reade) leaves on serum and hepatic lipid levels in rats. J Oleo Sci 2013 0.75
174 [A case of gastric endocrine cell carcinoma with liver metastasis showing rapid growth during pregnancy and marked reduction by systemic chemotherapy after delivery]. Nihon Shokakibyo Gakkai Zasshi 2006 0.75
175 Progressive congestive heart failure due to common iliac arteriovenous fistula: a case report. J Cardiol 2007 0.75
176 [A case of esophageal achalasia with flat elevated lesion in the esophagus]. Nihon Shokakibyo Gakkai Zasshi 2004 0.75
177 [Evaluation of transhepatic artery chemotherapy for highly advanced hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi 2010 0.75
178 Discrimination of fibrotic staging of chronic hepatitis C using multiple fibrotic markers. Hepatol Res 2013 0.75